Reference number : 236-2013-2014-Q4-00560, amendment number : , agreement type : G, recipient legal name : REMINGTON, Gary, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5S 2S1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 442650.0, agreement start date : 2014-04-01, agreement end date : 2018-03-31, description english : Clozapine Levels, Clinical Response, and Side Effects, description french : Clozapine Levels, Clinical Response, and Side Effects, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2014-15 to 2017-18), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2014-15 à 2017-18), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada